Starpharma Holdings Limited (ASX:SPL)
0.4100
-0.0400 (-8.89%)
Nov 10, 2026, 1:29 PM AEDT
Starpharma Holdings Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Starpharma Holdings stock has an average price target of $1.22. The average 1-year stock price forecast is 197.56% higher than the current stock price, while the lowest is $1.19 (+190.24%) and the highest is $1.25 (+204.88%).
Price Target: $1.22 (+197.56%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for Starpharma Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Jan '26 | Apr '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Financial Forecast
Revenue This Year
6.30M
from 12.67M
Decreased by -50.27%
Revenue Next Year
26.25M
from 6.30M
Increased by 316.67%
EPS This Year
-0.03
from -0.02
EPS Next Year
0.00
from -0.03
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.